NASDAQ: NEUP
Neuphoria Therapeutics Inc Stock Ownership - Who owns Neuphoria Therapeutics?

Insider buying vs selling

Have Neuphoria Therapeutics Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Lynx1 Capital Management LP10% Owner2025-10-21639,110$5.14
$3.28MBuy

1 of 1

NEUP insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when NEUP insiders and whales buy or sell their stock.

NEUP Shareholders

What type of owners hold Neuphoria Therapeutics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Spyros Papapetropoulos254.49%5,999,940$28.26MInsider
Peter Miles Winston Davies11.45%269,984$1.27MInsider
David Ian Wilson10.69%251,939$1.19MInsider
Lynx1 Capital Management LP10.02%236,218$1.11MInsider
Alan Fisher4.24%100,000$471.00kInsider
Advisorshares Investments LLC2.87%67,733$319.02kInstitution
Lynx1 Capital Management LP1.94%45,806$215.75kInstitution
Prosperity Wealth Management Inc1.26%29,750$140.12kInstitution
Citadel Advisors LLC0.62%14,606$68.79kInstitution
Merck Co Inc0.43%10,027$47.23kInstitution

1 of 2

NEUP vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
NEUP2.53%97.47%Net BuyingNet Buying
CLRB2.53%97.47%Net Buying
COCP0.79%99.21%
XTLB0.03%12.85%
EVGN1.50%0.00%

Neuphoria Therapeutics Stock Ownership FAQ

Who owns Neuphoria Therapeutics?

Neuphoria Therapeutics (NASDAQ: NEUP) is owned by 7.55% institutional shareholders, 290.89% Neuphoria Therapeutics insiders, and 0.00% retail investors. Spyros Papapetropoulos is the largest individual Neuphoria Therapeutics shareholder, owning 6.00M shares representing 254.49% of the company. Spyros Papapetropoulos's Neuphoria Therapeutics shares are currently valued at $27.48M.

If you're new to stock investing, here's how to buy Neuphoria Therapeutics stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.